DE69939732D1 - Apo-2 ligand - Google Patents
Apo-2 ligandInfo
- Publication number
- DE69939732D1 DE69939732D1 DE69939732T DE69939732T DE69939732D1 DE 69939732 D1 DE69939732 D1 DE 69939732D1 DE 69939732 T DE69939732 T DE 69939732T DE 69939732 T DE69939732 T DE 69939732T DE 69939732 D1 DE69939732 D1 DE 69939732D1
- Authority
- DE
- Germany
- Prior art keywords
- ligand
- apo
- antibodies
- believed
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000046283 TNF-Related Apoptosis-Inducing Ligand Human genes 0.000 title abstract 7
- 108700012411 TNFSF10 Proteins 0.000 title abstract 7
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 230000006907 apoptotic process Effects 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US788698A | 1998-01-15 | 1998-01-15 | |
US6053398A | 1998-04-15 | 1998-04-15 | |
PCT/US1999/001039 WO1999036535A1 (en) | 1998-01-15 | 1999-01-15 | Apo-2 ligand |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69939732D1 true DE69939732D1 (de) | 2008-11-27 |
Family
ID=26677483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69939732T Expired - Lifetime DE69939732D1 (de) | 1998-01-15 | 1999-01-15 | Apo-2 ligand |
Country Status (13)
Country | Link |
---|---|
US (1) | US6740739B1 (de) |
EP (2) | EP2017341A3 (de) |
JP (2) | JP2002508962A (de) |
AT (1) | ATE411385T1 (de) |
AU (1) | AU2325199A (de) |
CA (1) | CA2318029C (de) |
CY (1) | CY1108681T1 (de) |
DE (1) | DE69939732D1 (de) |
DK (1) | DK1045906T3 (de) |
ES (1) | ES2316182T3 (de) |
HK (1) | HK1032603A1 (de) |
PT (1) | PT1045906E (de) |
WO (1) | WO1999036535A1 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6284236B1 (en) | 1995-06-29 | 2001-09-04 | Immunex Corporation | Cytokine that induces apoptosis |
US20040038347A1 (en) * | 1996-03-14 | 2004-02-26 | Human Genome Sciences, Inc. | Apoptosis inducing molecule I |
EP1873244A3 (de) * | 1999-06-02 | 2008-04-02 | Genentech, Inc. | Verfahren und Zusammensetzungen zur Hemmung des neoplastischen Zellenwachstums |
ES2392392T3 (es) * | 1999-06-28 | 2012-12-10 | Genentech, Inc. | Métodos para producir ligando Apo-2 utilizando iones metálicos divalentes |
EP1501866A4 (de) * | 2001-10-02 | 2006-02-08 | Genentech Inc | Varianten des liganden apo-2 und verwendungen davon |
IL161812A0 (en) | 2001-11-13 | 2005-11-20 | Genentech Inc | Apo2 ligand/trail formulations |
US7741285B2 (en) | 2001-11-13 | 2010-06-22 | Genentech, Inc. | APO-2 ligand/trail formulations |
CN1313611C (zh) * | 2002-02-22 | 2007-05-02 | 中国人民解放军第二军医大学 | 新型肿瘤凋亡素2配体基因、其表达的肿瘤凋亡素及其制法 |
US20060141561A1 (en) * | 2002-06-24 | 2006-06-29 | Kelley Robert F | Apo-2 ligand/trail variants and uses thereof |
GB0328261D0 (en) * | 2003-12-05 | 2004-01-07 | Univ Groningen | Improved cytokine design |
US20080242603A1 (en) * | 2004-02-20 | 2008-10-02 | Yan Wang | Novel Apo2L and IL-24 Polypeptides, Polynucleotides, and Methods of Their Use |
AU2005271601A1 (en) * | 2004-08-06 | 2006-02-16 | Genentech, Inc. | Assays and methods using biomarkers |
AU2012200601B2 (en) * | 2004-08-06 | 2012-10-11 | Genentech, Inc. | Assays and methods using biomarkers |
JO3000B1 (ar) | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
US8029783B2 (en) | 2005-02-02 | 2011-10-04 | Genentech, Inc. | DR5 antibodies and articles of manufacture containing same |
WO2008061377A1 (en) * | 2006-11-22 | 2008-05-29 | Centre Hospitalier De L'universite De Montreal | Novel receptor for cd40l and uses thereof |
GB0724532D0 (en) * | 2007-12-17 | 2008-01-30 | Nat Univ Ireland | Trail variants for treating cancer |
US20110086770A1 (en) * | 2009-10-09 | 2011-04-14 | Anaphore, Inc. | Combinatorial Libraries Based on C-type Lectin-like Domain |
CA2812057A1 (en) | 2010-09-28 | 2012-04-05 | Kahr Medical Ltd. | Compositions and methods for treatment of hematological malignancies |
EP2704735A1 (de) | 2011-05-03 | 2014-03-12 | Genentech, Inc. | Vaskuläre disruptoren und ihre verwendung |
US9289468B2 (en) | 2011-09-16 | 2016-03-22 | Beijing Sunbio Biotech Co. Ltd. | Fusion protein comprising circularly permuted form of trail/Apo2L, coding gene and use thereof |
EP2684896A1 (de) | 2012-07-09 | 2014-01-15 | International-Drug-Development-Biotech | Antikörper gegen die DR5-Familie, bispezifische oder multivalente Antikörper gegen die DR5-Familie und Verfahren zu deren Verwendung |
DK2970473T3 (da) | 2013-03-14 | 2017-11-27 | Bristol Myers Squibb Co | Kombination af dr5-agonist og anti-pd-1-antagonist og fremgangsmåder til anvendelse heraf |
US9914761B2 (en) | 2014-07-10 | 2018-03-13 | Washington University | Oligomers for TNF superfamily inhibition |
UA126897C2 (uk) | 2015-12-01 | 2023-02-22 | Генмаб Б.В. | Антитіла проти dr5 і способи їх застосування |
LT3565579T (lt) | 2017-01-05 | 2023-09-11 | Kahr Medical Ltd. | Pd1-41bbl sulietas baltymas ir jo panaudojimo būdai |
IL267862B1 (en) | 2017-01-05 | 2024-01-01 | Kahr Medical Ltd | SIRPalpha-41BBL conjugate protein and methods of using it |
WO2018127918A1 (en) | 2017-01-05 | 2018-07-12 | Kahr Medical Ltd. | A sirp alpha-cd70 fusion protein and methods of use thereof |
WO2018127916A1 (en) | 2017-01-05 | 2018-07-12 | Kahr Medical Ltd. | A pd1-cd70 fusion protein and methods of use thereof |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3691016A (en) | 1970-04-17 | 1972-09-12 | Monsanto Co | Process for the preparation of insoluble enzymes |
CA1023287A (en) | 1972-12-08 | 1977-12-27 | Boehringer Mannheim G.M.B.H. | Process for the preparation of carrier-bound proteins |
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US4195128A (en) | 1976-05-03 | 1980-03-25 | Bayer Aktiengesellschaft | Polymeric carrier bound ligands |
US4330440A (en) | 1977-02-08 | 1982-05-18 | Development Finance Corporation Of New Zealand | Activated matrix and method of activation |
CA1093991A (en) | 1977-02-17 | 1981-01-20 | Hideo Hirohara | Enzyme immobilization with pullulan gel |
FR2413974A1 (fr) | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
US4229537A (en) | 1978-02-09 | 1980-10-21 | New York University | Preparation of trichloro-s-triazine activated supports for coupling ligands |
JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
US4342566A (en) | 1980-02-22 | 1982-08-03 | Scripps Clinic & Research Foundation | Solid phase anti-C3 assay for detection of immune complexes |
US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
US4419446A (en) | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
US4870009A (en) | 1982-11-22 | 1989-09-26 | The Salk Institute For Biological Studies | Method of obtaining gene product through the generation of transgenic animals |
US4601978A (en) | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
AU2353384A (en) | 1983-01-19 | 1984-07-26 | Genentech Inc. | Amplification in eukaryotic host cells |
US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
US4965199A (en) | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
NZ212207A (en) | 1984-05-31 | 1991-07-26 | Genentech Inc | Recombinant lymphotoxin |
US4736866A (en) | 1984-06-22 | 1988-04-12 | President And Fellows Of Harvard College | Transgenic non-human mammals |
DE3675588D1 (de) | 1985-06-19 | 1990-12-20 | Ajinomoto Kk | Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist. |
US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
EP0272253A4 (de) | 1986-03-07 | 1990-02-05 | Massachusetts Inst Technology | Verfahren zur verbesserung der glykoproteinstabilität. |
US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
US5010182A (en) | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
IL87737A (en) | 1987-09-11 | 1993-08-18 | Genentech Inc | Method for culturing polypeptide factor dependent vertebrate recombinant cells |
ES2058199T3 (es) | 1987-09-23 | 1994-11-01 | Bristol Myers Squibb Co | Heteroconjugados de anticuerpos para la eliminacion de celulas infectadas por el vih. |
GB8724885D0 (en) | 1987-10-23 | 1987-11-25 | Binns M M | Fowlpox virus promotors |
EP0321196A3 (de) | 1987-12-18 | 1990-07-18 | Mycogen Plant Science, Inc. | Transkriptionsaktivator des 780 T-DNA-Gens |
DE3889546T2 (de) | 1987-12-21 | 1994-09-08 | Univ Toledo | Transformation von keimenden pflanzensamen mit hilfe von agrobacterium. |
AU4005289A (en) | 1988-08-25 | 1990-03-01 | Smithkline Beecham Corporation | Recombinant saccharomyces |
FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
DK168302B1 (da) | 1989-06-29 | 1994-03-07 | Danisco | Fremgangsmåde til indføring af molekyler, især genetisk materiale i planteceller |
EP0479909B1 (de) | 1989-06-29 | 1996-10-30 | Medarex, Inc. | Bispezifische reagenzien für die aids-therapie |
ATE194384T1 (de) | 1989-09-12 | 2000-07-15 | Hoffmann La Roche | Tnf-bindende proteine |
ATE131872T1 (de) | 1989-11-22 | 1996-01-15 | Genentech Inc | Latenz assoziierte peptide und deren verwendung |
US5206161A (en) | 1991-02-01 | 1993-04-27 | Genentech, Inc. | Human plasma carboxypeptidase B |
WO1992020373A1 (en) | 1991-05-14 | 1992-11-26 | Repligen Corporation | Heteroconjugate antibodies for treatment of hiv infection |
WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
JPH08500017A (ja) | 1992-08-17 | 1996-01-09 | ジェネンテク,インコーポレイテッド | 二特異的免疫アドヘジン |
DE69405102T2 (de) | 1993-06-03 | 1998-01-15 | Therapeutic Antibodies Inc | Antikoerperfragmente in therapie |
WO1995010540A1 (en) | 1993-10-14 | 1995-04-20 | Immunex Corporation | Fas antagonists and uses thereof |
WO1995011301A1 (en) | 1993-10-19 | 1995-04-27 | The Regents Of The University Of Michigan | P53-mediated apoptosis |
IL111125A0 (en) | 1994-05-11 | 1994-12-29 | Yeda Res & Dev | Soluble oligomeric tnf/ngf super family ligand receptors and their use |
NZ311982A (en) | 1995-06-29 | 1999-08-30 | Immunex Corp | Tnf related apoptosis inducing ligand (trail), a method for producing them and associated antibodies |
US6284236B1 (en) * | 1995-06-29 | 2001-09-04 | Immunex Corporation | Cytokine that induces apoptosis |
US6030945A (en) * | 1996-01-09 | 2000-02-29 | Genentech, Inc. | Apo-2 ligand |
WO1997033899A1 (en) | 1996-03-14 | 1997-09-18 | Human Genome Sciences, Inc. | Apoptosis inducing molecule i |
WO1997046686A2 (en) | 1996-06-07 | 1997-12-11 | Amgen Inc. | Tumor necrosis factor-related polypeptide |
KR20020056565A (ko) | 2000-12-29 | 2002-07-10 | 황규언 | 인간유래 세포 소멸 인자와 그 수용체의 결합체인TRAIL-sDR5 결합체의 결정화에 의한 3차원 구조및 TRAIL 결실 돌연변이 단백질 |
AU2002258399A1 (en) | 2001-02-16 | 2002-09-19 | Medical College Of Georgia Research Institute, Inc. | Use of trail and antiprogestins for treating cancer |
-
1999
- 1999-01-15 EP EP08012755A patent/EP2017341A3/de not_active Withdrawn
- 1999-01-15 DE DE69939732T patent/DE69939732D1/de not_active Expired - Lifetime
- 1999-01-15 EP EP99903166A patent/EP1045906B1/de not_active Expired - Lifetime
- 1999-01-15 ES ES99903166T patent/ES2316182T3/es not_active Expired - Lifetime
- 1999-01-15 AT AT99903166T patent/ATE411385T1/de active
- 1999-01-15 WO PCT/US1999/001039 patent/WO1999036535A1/en active Application Filing
- 1999-01-15 AU AU23251/99A patent/AU2325199A/en not_active Abandoned
- 1999-01-15 US US09/582,450 patent/US6740739B1/en not_active Expired - Lifetime
- 1999-01-15 PT PT99903166T patent/PT1045906E/pt unknown
- 1999-01-15 DK DK99903166T patent/DK1045906T3/da active
- 1999-01-15 CA CA002318029A patent/CA2318029C/en not_active Expired - Lifetime
- 1999-01-15 JP JP2000540237A patent/JP2002508962A/ja not_active Withdrawn
-
2001
- 2001-03-31 HK HK01102353.6A patent/HK1032603A1/xx not_active IP Right Cessation
-
2008
- 2008-12-17 CY CY20081101467T patent/CY1108681T1/el unknown
-
2010
- 2010-07-02 JP JP2010151519A patent/JP2010246560A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1045906A1 (de) | 2000-10-25 |
DK1045906T3 (da) | 2009-02-16 |
PT1045906E (pt) | 2009-01-27 |
ES2316182T3 (es) | 2009-04-01 |
WO1999036535A9 (en) | 2000-03-02 |
EP2017341A3 (de) | 2009-04-08 |
HK1032603A1 (en) | 2001-07-27 |
EP2017341A2 (de) | 2009-01-21 |
WO1999036535A1 (en) | 1999-07-22 |
EP1045906B1 (de) | 2008-10-15 |
AU2325199A (en) | 1999-08-02 |
ATE411385T1 (de) | 2008-10-15 |
CA2318029C (en) | 2009-05-19 |
CY1108681T1 (el) | 2014-04-09 |
US6740739B1 (en) | 2004-05-25 |
CA2318029A1 (en) | 1999-07-22 |
JP2010246560A (ja) | 2010-11-04 |
JP2002508962A (ja) | 2002-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0873407T3 (da) | Apo-2-ligand | |
DE69939732D1 (de) | Apo-2 ligand | |
LUC00121I1 (de) | ||
DE69838249D1 (de) | Anti-apo-2 antikörper | |
IS6322A (is) | Viðtaki APRIL (BCMA) og notkun hans | |
DK0988301T3 (da) | Imidazolylcykliske acetaler | |
TW200716745A (en) | Anti-TNF antibodies, compositions, methods and uses | |
DK1032672T3 (da) | DNA19355-polypeptid, en tumornekrosefaktor-homolog | |
DK1009817T3 (da) | RTD-receptor | |
DK0939769T3 (da) | Vertebrat-Smoothened-proteiner | |
ATE236983T1 (de) | Durch zelldichte stimulierte protein-tyrosin- phosphatasen | |
ATE402258T1 (de) | Gene differentiell experimiert in brudtkrebs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |